Advanced Biomed Inc. Common Stock

10-Year Study

ADVB.US · Healthcare · US · Common Stock

Executive Summary: Advanced Biomed Inc. Common Stock has compounded at -92.4% annually over the last 10 years, with a maximum drawdown of 94.8% and an annualized volatility of 2072.5%.

1Y CAGR
-79.7%
3Y CAGR
-92.4%
5Y CAGR
-92.4%
10Y CAGR
-92.4%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
94.8%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
-1.21
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
-1.85
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
76.9%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2026 · +-18.3%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2026 · -18.3%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
0%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
20263.5-32.712.24.6————————-18.3%
2025———-51.0-46.4-32.0-33.9-8.96.37.3-12.6-30.5-92.6%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 2072.5%. The dominant macroeconomic risk driver is VTI.US, accounting for 33.2% of variance. Idiosyncratic stock-specific factors contribute 0.0%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2025-03-0110000
2025-04-014899.489795918367
2025-05-012627.2959183673465
2025-06-011785.7142857142856
2025-07-011179.5918367346937
2025-08-011075
2025-09-011143.112244897959
2025-10-011226.0204081632653
2025-11-011071.6836734693875
2025-12-01744.3877551020408
2026-01-01770.1530612244898
2026-02-01518.1632653061224
2026-03-01581.6326530612243
2026-04-01608.4183673469387
Annual Return Matrix
YearAnnual Return
2026-0.1826593557230981
Total Factor Risk
20.725177379142522
VTI.US Exposure
0.33211497252493244
VEA.US Exposure
-0.0029979986432480507
VWO.US Exposure
0.06163754584665515
QQQ.US Exposure
0.0953978155726301
VTV.US Exposure
-0.005385936372075495
IJR.US Exposure
-0.0013284574716188721
QUAL.US Exposure
0.0065466823176056725
SHV.US Exposure
0.14889065778133598
TLT.US Exposure
0.10241849334272943
LQD.US Exposure
0.012447052732834387
HYG.US Exposure
0.028628985185985636
GLD.US Exposure
0.014865475623025676
USO.US Exposure
0.010068918439944004
VNQ.US Exposure
0.02877015338975939
BTC-USD.CC Exposure
0.00003020709196866251
CPER.US Exposure
-0.00061489257792632
VIX.INDX Exposure
0.0195909683543692
UUP.US Exposure
0.0058874255222834985
TIP.US Exposure
0.14303193131552838
Idiosyncratic Exposure
2.328109953420234e-11
Value Score
49.5
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
2072.5%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →1.3x
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$6.2M
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-0.5%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-39.5%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
88.5% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
1.00
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is Advanced Biomed Inc. Common Stock a high-risk investment?

Advanced Biomed Inc. Common Stock (ADVB.US) has an annualized volatility of 2072.5% and experienced a maximum drawdown of 94.8% over the last 10 years. Its primary macro risk driver is VTI.US.

What is the 10-year return of ADVB.US?

Over the past 10 years, ADVB.US has generated a Compound Annual Growth Rate (CAGR) of -92.4%. It has had a positive return in 0% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Advanced Biomed Inc. Common Stock

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest